Apogee Therapeutics Stock (NASDAQ: APGE) stock price, news, charts, stock research, profile.
Open | $53.45 |
Close | $58.43 |
Volume / Avg. | 1.81M / 447.86K |
Day Range | $52.96 - $59.90 |
52 Wk Range | 14.19 - 72.29 |
Market Cap | $3.30B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 72 |
Short Interest | 21.52% |
Days to Cover | 28.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Apogee Therapeutics (NASDAQ:APGE) through any online brokerage.
Other companies in Apogee Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
Apogee Therapeutics has a consensus price target of $70.67.
The stock price for Apogee Therapeutics (NASDAQ: APGE) is $58.22 last updated September 20, 2024 at 7:25 PM EDT.
There are no upcoming dividends for Apogee Therapeutics.
Apogee Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Apogee Therapeutics.
Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.